Perrigo Co.’s Opill received U.S. clearance for over-the-counter use, making it the first daily oral birth-control product to be available without a prescription in the U.S. The decision released Thursday
WASHINGTON — White House and Republican negotiators tentatively narrowed differences but were still clashing Friday on key issues as the Treasury Department signaled extra time was available before a potential
Drugmaker Perrigo Co.’s shares fell after U.S. regulators raised concerns about whether its birth-control product Opill would be suitable as an over-the-counter drug. Opill may not be effective as a
SANTA CLARA, California — Federal officials moved to insure all deposits at failed Silicon Valley Bank, hoping to inoculate the banking system against contagion, but shares of another Bay Area
The Federal Reserve’s preferred inflation gauges unexpectedly accelerated in January and consumer spending surged after a year-end slump, adding pressure on policymakers to keep ratcheting up interest rates. The personal